Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, February 06, 2023
The Association of Diversity in Clinical Trials (AOD) is being launched and introduced at upcoming industry conferences SCOPE and the Health Equity in Clinical Trials Congress this month. The AOD will become the first entity to represent industry in ...
read more
TFS HealthScience (TFS), a global contract research organization (CRO), announced the appointment of long-standing member of the company, Miriam Martin , as Vice President of Business Development, Clinical Development Services (CDS).
read more
Thursday, November 03, 2022
TFF Pharmaceuticals announced a collaboration with Aptar Pharma aimed at developing and testing the administration of dry powder vaccines utilizing TFF Pharmaceutical’s Thin Film Freezing technology and Aptar Pharma’s proprietary intranasal Unidose (...
read more
TFF Pharmaceuticals announced the USPTO has issued a Notice of Allowance for U.S. Patent Application No. 12/778,795, "Compositions and Methods of Making Brittle-Matrix Particles Through Blister Pack Freezing."
read more
TFF Pharmaceuticals, Inc. and Catalent announced their collaboration agreement focused on the generation, testing and manufacture of dry powder formulations for a range of biotherapeutics through the application of TFF Pharmaceuticals’ patented Thin ...
read more
Tuesday, January 13, 2015
Platinum Press, Inc. (PPI) – a leading provider of healthcare packaging solutions for the pharmaceutical, medical device and animal care sectors that specializes in labels, folding cartons, blister packaging, inserts/outserts and medication guides – ...
read more
Wednesday, September 11, 2019
Kinaxis will help Teva connect its data, processes and people into a single platform to transform its global supply chain, improve visibility and operational efficiencies.
read more
Thursday, February 08, 2018
During the fourth quarter of 2017, the company noted further deterioration in the U.S. generics market and economic environment.
read more
Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. and its affiliates, has reached an agreement with the Attorney General of West Virginia that settles the state’s and its subdivisions opioid-related claims.
read more
Wednesday, February 24, 2016
Teva Pharmaceutical Industries is embarking on a strategic enterprise-wide corporate identity program to build a global brand.
read more
Monday, September 11, 2017
Teva Pharmaceutical announced its Board of Directors has named Kåre Schultz to become the company’s President and Chief Executive Officer.
read more
Wednesday, February 20, 2019
Teva Pharmaceutical announced a settlement with the Federal Trade Commission (FTC) that will resolve all outstanding litigation between the parties.
read more
Teva announced the company has completed the purchase of three buildings on Brandywine Parkway in West Chester, Pa.
read more
Thursday, December 27, 2018
Teva Pharmaceutical announced the launch of a generic version of Elidel1 (pimecrolimus) Cream, 1% in the U.S.
read more
Friday, February 16, 2018
Teva announced QVAR RediHaler Inhalation Aerosol is now commercially available to patients in both 40 mcg and 80 mcg strengths by prescription in the U.S.
read more